Browsing by Author Armendariz-Borunda, J.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 160  next >
Issue DateTitleAuthor(s)
2012A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patientsArmendariz-Borunda, J.; Lyra-Gonzalez, I.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Martinez-Fong, D.; Miranda, R.A.; Magana-Castro, R.; Pena-Santoyo, P.; Garcia-Rocha, S.; Bautista, C.A.; Godoy, J.; Flores-Montana, J.; Floresvillar-Mosqueda, J.; Armendariz-Vazquez, O.; Lucano-Landeros, M.S.; Vazquez-Del Mercado, M.; Sanchez-Parada, M.G.; Armendariz-Borunda, J., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico, OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Lyra-Gonzalez, I., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico; Medina-Preciado, D., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Gonzalez-García, I., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Martinez-Fong, D., Department of Physiology, Biophysics and Neurosciences, CINVESTAV, Mexico D.F., Mexico; Miranda, R.A., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Magaña-Castro, R., Cell Therapy and Technology, S.A. de C.V., Mexico D.F., Mexico; Peña-Santoyo, P., Cell Therapy and Technology, S.A. de C.V., Mexico D.F., Mexico; Garcia-Rocha, S., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Bautista, C.A., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Godoy, J., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Flores-Montana, J., Faculty of Medicine, Autonomous University of Chihuahua, Chihuahua, Mexico; Floresvillar-Mosqueda, J., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico; Armendariz-Vazquez, O., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico; Lucano-Landeros, M.S., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico; Vazquez-Del Mercado, M., Institute for Rheumatology and Muscle- Skeletal Research, CUCS, University of Guadalajara, Guadalajara, Mexico; Sanchez-Parada, M.G., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico
2012A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patientsArmendariz-Borunda, J.; Lyra-Gonzalez, I.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Martinez-Fong, D.; Miranda, R.A.; Magana-Castro, R.; Pena-Santoyo, P.; Garcia-Rocha, S.; Bautista, C.A.; Godoy, J.; Flores-Montana, J.; Floresvillar-Mosqueda, J.; Armendariz-Vazquez, O.; Lucano-Landeros, M.S.; Vazquez-Del Mercado, M.; Sanchez-Parada, M.G.; Armendariz-Borunda, J., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico, OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Lyra-Gonzalez, I., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico; Medina-Preciado, D., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Gonzalez-Garc�a, I., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Martinez-Fong, D., Department of Physiology, Biophysics and Neurosciences, CINVESTAV, Mexico D.F., Mexico; Miranda, R.A., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Maga�a-Castro, R., Cell Therapy and Technology, S.A. de C.V., Mexico D.F., Mexico; Pe�a-Santoyo, P., Cell Therapy and Technology, S.A. de C.V., Mexico D.F., Mexico; Garcia-Rocha, S., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Bautista, C.A., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Godoy, J., OPD, Hospital Civil de Guadalajara, Guadalajara, Mexico; Flores-Montana, J., Faculty of Medicine, Autonomous University of Chihuahua, Chihuahua, Mexico; Floresvillar-Mosqueda, J., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico; Armendariz-Vazquez, O., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico; Lucano-Landeros, M.S., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico; Vazquez-Del Mercado, M., Institute for Rheumatology and Muscle- Skeletal Research, CUCS, University of Guadalajara, Guadalajara, Mexico; Sanchez-Parada, M.G., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Mexico
2012A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients: ReplyArmendariz-Borunda, J.; Armendariz-Borunda, J., Department of Molecular Biology and Genomics, CUCS, University of Guadalajara, Guadalajara, Mexico
2012A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients: ReplyArmendariz-Borunda, J.; Armendariz-Borunda, J., Department of Molecular Biology and Genomics, CUCS, University of Guadalajara, Guadalajara, Mexico
1999A novel sodium benzoate analog (CH-1) decreases blood ammonia levels in experimental hyperammonemiaCampollo, O.; Cortez, R.; Odor, A.; Maria Munoz, R.; Armendariz-Borunda, J.; Alvarez-Tostado, J.; Campollo, O.; Cortez, R.; Odor, A.; Maria Muñoz, R.; Armendariz-Borunda, J., Inst. de Biol. Molecular en Medicina, C.U.C.S. Universidad de Guadalajara, Guadalajara, Mexico; Alvarez-Tostado, J.
1999A novel sodium benzoate analog (CH-1) decreases blood ammonia levels in experimental hyperammonemiaCampollo, O.; Cortez, R.; Odor, A.; Maria Munoz, R.; Armendariz-Borunda, J.; Alvarez-Tostado, J.; Campollo, O.; Cortez, R.; Odor, A.; Maria Muñoz, R.; Armendariz-Borunda, J., Inst. de Biol. Molecular en Medicina, C.U.C.S. Universidad de Guadalajara, Guadalajara, Mexico; Alvarez-Tostado, J.
2008A performance analysis framework for WiFi/WiMAX heterogeneous metropolitan networks based on cross-layer designFernandez, T.V.; García-Gonzalez, I.J.; Mason, C.E.; Hernandez-Zaragoza, G.; Ledezma-Rodriguez, V.C.; Anguiano-Alvarez, V.M.; E'Vega, R.; Gutierrez-Angulo, M.; Maya, M.L.; García-Bejarano, H.E.; Gonzalez-Cruz, M.; Barrios, S.; Atorga, R.; Lopez-Cardona, M.G.; Armendariz-Borunda, J.; State, M.W.; Davalos, N.O.; Fernandez, T.V., Yale Child Study Center, Yale University School of Medicine, New Haven, CT, United States, Yale Child Study Center, Yale University School of Medicine, 230 South Frontage Road, New Haven, CT 06520-7900, United States; García-González, I.J., Instituto de Genética Humana, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Mason, C.E., Department of Genetics, Yale University School of Medicine, New Haven, CT, United States, Program on Neurogenetics, Yale University School of Medicine, New Haven, CT, United States; Hernández-Zaragoza, G., Instituto de Genética Humana, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Ledezma-Rodríguez, V.C., Instituto de Genética Humana, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Anguiano-Alvarez, V.M., Instituto de Genética Humana, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; E'Vega, R., Instituto de Genética Humana, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Gutiérrez-Angulo, M., Instituto de Genética Humana, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Maya, M.L., Hospital Regional Dr. Valentin Gómez Farías ISSSTE, Serv. Endocrinología, Guadalajara, Jalisco, Mexico; García-Bejarano, H.E., Hospital Regional Dr. Valentin Gómez Farías ISSSTE, Serv. Nefrología, Guadalajara, Jalisco, Mexico; González-Cruz, M., Hospital Regional Dr. Valentin Gómez Farías ISSSTE, Serv. Neuropediatría, Guadalajara, Jalisco, Mexico; Barrios, S., Hospital Regional Dr. Valentin Gómez Farías ISSSTE, Serv. Cardiopediatría, Guadalajara, Jalisco, Mexico; Atorga, R., Hospital Regional Dr. Valentin Gómez Farías ISSSTE, Serv. Otorrinolaringología, Guadalajara, Jalisco, Mexico; López-Cardona, M.G., Instituto de Genética Humana, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Hospital Regional Dr. Valentin Gómez Farías ISSSTE, Serv. Genética, Guadalajara, Jalisco, Mexico; Armendariz-Borunda, J., Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; State, M.W., Yale Child Study Center, Yale University School of Medicine, New Haven, CT, United States, Department of Genetics, Yale University School of Medicine, New Haven, CT, United States, Program on Neurogenetics, Yale University School of Medicine, New Haven, CT, United States, Yale Child Study Center, Yale University School of Medicine, 230 South Frontage Road, New Haven, CT 06520-7900, United States; Dávalos, N.O., Instituto de Genética Humana, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Biología Molecular Y Genómica, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Hospital Regional Dr. Valentin Gómez Farías ISSSTE, Serv. Genética, Guadalajara, Jalisco, Mexico
2006A pilot study in patients with established advanced liver fibrosis using pirfenidone [4]Armendariz-Borunda, J.; Islas-Carbajal, M.C.; Meza-Garcia, E.; Rincon, A.R.; Lucano, S.; Sandoval, A.S.; Salazar, A.; Berumen, J.; Alvarez, A.; Alvarez, A.; Covarrubias, A.; Arechiga, G.; Garcia, L.; Armendáriz-Borunda, J., Institute for Molecular Biology in Medicine and Gene Therapy, Guadalajara, Jalisco, Mexico, OPD Civil Hospital of Guadalajara, Guadalajara, Jalisco, Mexico, Institute for Molecular Biology in Medicine and Gene Therapy, Apdo Postal 2-123, Guadalajara, Jalisco 44281, Mexico; Islas-Carbajal, M.C., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Meza-García, E., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Rincón, A.R., Institute of Chronic Degenerative Diseases, Guadalajara, Jalisco, Mexico; Lucano, S., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Sandoval, A.S., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Salazar, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Berumen, J., Unit of Genomic Medicine, General Hospital of México, México, Mexico; Alvarez, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Alvarez, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Covarrubias, A., OPD Civil Hospital of Guadalajara, Guadalajara, Jalisco, Mexico; Aréchiga, G., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; García, L., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico
2006A pilot study in patients with established advanced liver fibrosis using pirfenidone [4]Armendariz-Borunda, J.; Islas-Carbajal, M.C.; Meza-Garcia, E.; Rincon, A.R.; Lucano, S.; Sandoval, A.S.; Salazar, A.; Berumen, J.; Alvarez, A.; Alvarez, A.; Covarrubias, A.; Arechiga, G.; Garcia, L.; Armend�riz-Borunda, J., Institute for Molecular Biology in Medicine and Gene Therapy, Guadalajara, Jalisco, Mexico, OPD Civil Hospital of Guadalajara, Guadalajara, Jalisco, Mexico, Institute for Molecular Biology in Medicine and Gene Therapy, Apdo Postal 2-123, Guadalajara, Jalisco 44281, Mexico; Islas-Carbajal, M.C., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Meza-Garc�a, E., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Rinc�n, A.R., Institute of Chronic Degenerative Diseases, Guadalajara, Jalisco, Mexico; Lucano, S., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Sandoval, A.S., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Salazar, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Berumen, J., Unit of Genomic Medicine, General Hospital of M�xico, M�xico, Mexico; Alvarez, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Alvarez, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Covarrubias, A., OPD Civil Hospital of Guadalajara, Guadalajara, Jalisco, Mexico; Ar�chiga, G., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico; Garc�a, L., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Guadalajara, Jalisco, Mexico
2014A single dose of pirfenidone attenuates neuronal loss and reduces lipid peroxidation after kainic acid-induced excitotoxicity in the pubescent rat hippocampusCastro-Torres, R.D.; Chaparro-Huerta, V.; Flores-Soto, M.E.; Banuelos-Pineda, J.; Camins, A.; Orozco-Suarez, S.A.; Armendariz-Borunda, J.; Beas-Zárate, Carlos; Castro-Torres, R.D., Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Guadalajara Jalisco 44421, Mexico; Chaparro-Huerta, V., Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Guadalajara Jalisco 44421, Mexico; Flores-Soto, M.E., Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Guadalajara Jalisco 44421, Mexico; Bañuelos-Pineda, J., Lab. Neuromorfología, Depto. de Medicina Veterinaria, Universidad de Guadalajara, Guadalajara, Mexico; Camins, A., Unitat de Farcalogia i Farmacognosia, Facultat de Farmacia, Centros de Investigacion Biomedica en Red Enfermedades Neurodegenerativas, Nuclei Universtari de Pedralbes, 08028 Barcelona, Spain; Orozco-Suárez, S.A., Unidad de Investigación Médica en Enfermedades Neurológicas, Centro Médico Nacional XXII IMSS, México DF Mexico, Mexico; Armendáriz-Borunda, J., Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Guadalajara, Mexico, INNOVARE, Guadalajara Jalisco, Mexico; Beas-Zárate, C., Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Guadalajara Jalisco 44421, Mexico, Carlos Beas Zárate, Departamento de Biología Celular y Molecular, Universidad de Guadalajara, Km. 15.5 Carr GDL-Nogales, Nextipac, Zapopan Jalisco 45110, Mexico; Beas-Zárate, Carlos., Universidad de Guadalajara. Centro Universitario de Ciencias Biológicas y Agropecuarias
2014A single dose of pirfenidone attenuates neuronal loss and reduces lipid peroxidation after kainic acid-induced excitotoxicity in the pubescent rat hippocampusCastro-Torres, R.D.; Chaparro-Huerta, V.; Flores-Soto, M.E.; Banuelos-Pineda, J.; Camins, A.; Orozco-Suarez, S.A.; Armendariz-Borunda, J.; Beas-Zárate, Carlos; Castro-Torres, R.D., Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Guadalajara Jalisco 44421, Mexico; Chaparro-Huerta, V., Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Guadalajara Jalisco 44421, Mexico; Flores-Soto, M.E., Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Guadalajara Jalisco 44421, Mexico; Bañuelos-Pineda, J., Lab. Neuromorfología, Depto. de Medicina Veterinaria, Universidad de Guadalajara, Guadalajara, Mexico; Camins, A., Unitat de Farcalogia i Farmacognosia, Facultat de Farmacia, Centros de Investigacion Biomedica en Red Enfermedades Neurodegenerativas, Nuclei Universtari de Pedralbes, 08028 Barcelona, Spain; Orozco-Suárez, S.A., Unidad de Investigación Médica en Enfermedades Neurológicas, Centro Médico Nacional XXII IMSS, México DF Mexico, Mexico; Armendáriz-Borunda, J., Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Guadalajara, Mexico, INNOVARE, Guadalajara Jalisco, Mexico; Beas-Zárate, C., Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Guadalajara Jalisco 44421, Mexico, Carlos Beas Zárate, Departamento de Biología Celular y Molecular, Universidad de Guadalajara, Km. 15.5 Carr GDL-Nogales, Nextipac, Zapopan Jalisco 45110, Mexico; Beas-Zárate, Carlos., Universidad de Guadalajara. Centro Universitario de Ciencias Biológicas y Agropecuarias
1999Addition of anti-CD28 antibodies restores PBMC proliferation and IFN-? production in lepromatous leprosy patientsFafutis-Morris, M.; Guillen-Vargas, C.M.; Navarro-Fierros, S.; Alfaro-Bustamante, F.; Zaitzeva-Petrovna, G.; Daneri-Navarro, Adrián; Santoscoy-Tovar, L.; Armendariz-Borunda, J.; Fafutis-Morris, M., Ctro. de Invest. en Inmunologia y D., C.U.C.S., Inst. Dermatologico de Jalisco, Mexico, Ctro. de Invest. en Inmunologia y D., CUCS Univ. de Guadalajara, Inst. Dermatologico de Jalisco, Av. Federalismo Norte 3102, Guadalajara Jal., Mexico; Guillén-Vargas, C.M., Ctro. de Invest. en Inmunologia y D., C.U.C.S., Inst. Dermatologico de Jalisco, Mexico; Navarro-Fierros, S., Ctro. de Invest. en Inmunologia y D., C.U.C.S., Inst. Dermatologico de Jalisco, Mexico; Alfaro-Bustamante, F., Ctro. Univ. de Cie. Biol. y A., Universidad de Guadalajara, Mexico; Zaitzeva-Petrovna, G., Ctro. Univ. de Cie. Biol. y A., Universidad de Guadalajara, Mexico; Daneri-Navarro, A., Departamento de Fisiologia, C.U.C.S, Universidad de Guadalajara, Mexico; Santoscoy-Tovar, L., Unidad de Patologia Clinica, Guadalajara, Jalisco, Mexico; Armendariz-Borunda, J., Inst. de Biol. Molecular en Medicina, C.U.C.S, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Daneri-Navarro, Adrián., Universidad de Guadalajara. Centro Universitario de Ciencias de la Salud
1999Addition of anti-CD28 antibodies restores PBMC proliferation and IFN-γ production in lepromatous leprosy patientsFafutis-Morris, M.; Guillen-Vargas, C.M.; Navarro-Fierros, S.; Alfaro-Bustamante, F.; Zaitzeva-Petrovna, G.; Daneri-Navarro, Adrián; Santoscoy-Tovar, L.; Armendariz-Borunda, J.; Fafutis-Morris, M., Ctro. de Invest. en Inmunologia y D., C.U.C.S., Inst. Dermatologico de Jalisco, Mexico, Ctro. de Invest. en Inmunologia y D., CUCS Univ. de Guadalajara, Inst. Dermatologico de Jalisco, Av. Federalismo Norte 3102, Guadalajara Jal., Mexico; Guillén-Vargas, C.M., Ctro. de Invest. en Inmunologia y D., C.U.C.S., Inst. Dermatologico de Jalisco, Mexico; Navarro-Fierros, S., Ctro. de Invest. en Inmunologia y D., C.U.C.S., Inst. Dermatologico de Jalisco, Mexico; Alfaro-Bustamante, F., Ctro. Univ. de Cie. Biol. y A., Universidad de Guadalajara, Mexico; Zaitzeva-Petrovna, G., Ctro. Univ. de Cie. Biol. y A., Universidad de Guadalajara, Mexico; Daneri-Navarro, A., Departamento de Fisiologia, C.U.C.S, Universidad de Guadalajara, Mexico; Santoscoy-Tovar, L., Unidad de Patologia Clinica, Guadalajara, Jalisco, Mexico; Armendariz-Borunda, J., Inst. de Biol. Molecular en Medicina, C.U.C.S, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Daneri-Navarro, Adrián., Universidad de Guadalajara. Centro Universitario de Ciencias de la Salud
2012Adeno-associated viral vectors: Methods for production and purification for gene therapy applications [Vectores virales adeno-asociados: Métodos de producción, purificación y aplicaciones en terapia génica]Mena-Enriquez, M.; Flores-Contreras, L.; Armendariz-Borunda, J.; Mena-Enriquez, M., Instituto de Biología Molecular en Medicina Y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada, Núm. 950 Col. Independencia, 44340, Guadalajara, Jal., Mexico; Flores-Contreras, L., Instituto de Biología Molecular en Medicina Y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada, Núm. 950 Col. Independencia, 44340, Guadalajara, Jal., Mexico; Armendáriz-Borunda, J., Instituto de Biología Molecular en Medicina Y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada, Núm. 950 Col. Independencia, 44340, Guadalajara, Jal., Mexico
2012Adeno-associated viral vectors: Methods for production and purification for gene therapy applications [Vectores virales adeno-asociados: Métodos de producción, purificación y aplicaciones en terapia gúnica]Mena-Enriquez, M.; Flores-Contreras, L.; Armendariz-Borunda, J.; Mena-Enriquez, M., Instituto de Biología Molecular en Medicina Y Terapia Gúnica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada, Núm. 950 Col. Independencia, 44340, Guadalajara, Jal., Mexico; Flores-Contreras, L., Instituto de Biología Molecular en Medicina Y Terapia Gúnica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada, Núm. 950 Col. Independencia, 44340, Guadalajara, Jal., Mexico; Armendáriz-Borunda, J., Instituto de Biología Molecular en Medicina Y Terapia Gúnica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada, Núm. 950 Col. Independencia, 44340, Guadalajara, Jal., Mexico
2009Adenoviral delivery of dominant-negative transforming growth factor ? type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in ratsMarquez-Aguirre, A.; Sandoval-Rodriguez, A.; Gonzalez-Cuevas, J.; Bueno-Topete, M.; Navarro-Partida, J.; Arellano-Olivera, I.; Lucano-Landeros, S.; Armendariz-Borunda, J.; Marquez-Aguirre, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Sandoval-Rodriguez, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Gonzalez-Cuevas, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Bueno-Topete, M., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Navarro-Partida, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Arellano-Olivera, I., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Lucano-Landeros, S., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Armendariz-Borunda, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico, OPD Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
2009Adenoviral delivery of dominant-negative transforming growth factor β type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in ratsMarquez-Aguirre, A.; Sandoval-Rodriguez, A.; Gonzalez-Cuevas, J.; Bueno-Topete, M.; Navarro-Partida, J.; Arellano-Olivera, I.; Lucano-Landeros, S.; Armendariz-Borunda, J.; Marquez-Aguirre, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Sandoval-Rodriguez, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Gonzalez-Cuevas, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Bueno-Topete, M., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Navarro-Partida, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Arellano-Olivera, I., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Lucano-Landeros, S., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Armendariz-Borunda, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico, OPD Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
2013Adenoviral gene therapy in hepatocellular carcinoma: A reviewLyra-Gonzalez, I.; Flores-Fong, L.E.; Gonzalez-Garcia, I.; Medina-Preciado, D.; Armendariz-Borunda, J.; Lyra-González, I., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Sierra Mojada #950, Guadalajara, JAL 44281, Mexico; Flores-Fong, L.E., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Sierra Mojada #950, Guadalajara, JAL 44281, Mexico; González-García, I., O.P.D. Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, JAL, Mexico; Medina-Preciado, D., O.P.D. Hospital Civil de Guadalajara, Juan I. Menchaca, Guadalajara, JAL, Mexico; Armendáriz-Borunda, J., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Sierra Mojada #950, Guadalajara, JAL 44281, Mexico, O.P.D. Hospital Civil de Guadalajara, Juan I. Menchaca, Guadalajara, JAL, Mexico
2013Adenoviral gene therapy in hepatocellular carcinoma: A reviewLyra-Gonzalez, I.; Flores-Fong, L.E.; Gonzalez-García, I.; Medina-Preciado, D.; Armendariz-Borunda, J.; Lyra-González, I., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Sierra Mojada #950, Guadalajara, JAL 44281, Mexico; Flores-Fong, L.E., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Sierra Mojada #950, Guadalajara, JAL 44281, Mexico; González-García, I., O.P.D. Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, JAL, Mexico; Medina-Preciado, D., O.P.D. Hospital Civil de Guadalajara, Juan I. Menchaca, Guadalajara, JAL, Mexico; Armendáriz-Borunda, J., Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Sierra Mojada #950, Guadalajara, JAL 44281, Mexico, O.P.D. Hospital Civil de Guadalajara, Juan I. Menchaca, Guadalajara, JAL, Mexico
2010Alpha-lipoic acid regulates heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cellsHuerta-Olvera, S.G.; Macias-Barragan, J.; Ramos-Marquez, M.E.; Armendariz-Borunda, J.; Diaz-Barriga, F.; Siller-Lopez, F.; Huerta-Olvera, S.G., Doctorado en Ciencias Biomédicas Básicas, Universidad Autónoma de San Luis Potosí, Mexico, OPD Hospital Civil de Guadalajara, Mexico; Macías-Barragán, J., Doctorado en Ciencias Biomédicas, Universidad de Guadalajara, Mexico; Ramos-Márquez, M.E., Instituto de Enfermedades Crónico-degenerativas, Universidad de Guadalajara, Mexico; Armendáriz-Borunda, J., OPD Hospital Civil de Guadalajara, Mexico, Instituto de Biología Molecular en Medicina, Universidad de Guadalajara, Mexico; Díaz-Barriga, F., Unidad de Toxicología Ambiental, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, Mexico; Siller-López, F., Instituto de Oftalmología y Ciencias Visuales, Universidad de Guadalajara, Mexico, Centro de Investigación en Inmunología y Dermatología, Universidad de Guadalajara, Mexico